Rare Disease Trial, Recruiting (NCT04181970)

Rare Disease Trial, Recruiting NCT04181970 Sponsor: Grupo Espanol de Investigacion en Sarcomas Condition: Rare Disease

Printed from Voxsanity (voxsanity.com.au) — NCT04181970 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Rare Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with a type of cancer called soft-tissue sarcoma, GIST (gastrointestinal stromal tumour), or bone sarcoma (any subtype), confirmed by a tissue sample (biopsy), between January 2005 and June/September 2023
You are 18 years old or older
Your medical records and treatment history are available for review

Who may not be able to join:

There are no stated exclusion criteria for this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Javier MARTIN-BROTO, MD, Salud de Madrid

Phone: +34 910908102

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04181970

Sponsor: Grupo Espanol de Investigacion en Sarcomas

Phase: Not Applicable

Status: Recruiting

Condition: Rare Disease

Trial contact: +34 910908102

More information: https://clinicaltrials.gov/study/NCT04181970

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with a type of cancer called soft-tissue sarcoma, GIST (gastrointestinal stromal tumour), or bone sarcoma (any subtype), confirmed by a tissue sample (biopsy), between January 2005 and June/September 2023
You are 18 years old or older
Your medical records and treatment history are available for review

Who may not be able to join:

There are no stated exclusion criteria for this trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Grupo Espanol de Investigacion en Sarcomas

Registry

ClinicalTrials.gov

Start date

30 June 2019

Est. completion

30 September 2026

Where this trial is recruiting

🇦🇷 Argentina 🇧🇷 Brazil Costa Rica 🇫🇷 France 🇮🇹 Italy 🇲🇽 Mexico 🇵🇪 Peru 🇪🇸 Spain

Primary endpoints

Percentage of cases with > 5 cm with tru-cut biopsies.; Percentage of biopsies carried out by sarcoma teams vs not sarcoma team; Percentage of patients with image studies at diagnosis and before surgery.; Percentage of patients discussed in Multidisciplinary Team before treatment; Percentage of patients with specified histopathological grade in pathologic report.; Percentage of affected surgical margins in first surgery; Percentage of re-resections in patients with affected surgical margins in first surgery; percentage of patients with >5 cm and G2-3 sarcoma receiving neo/adjuvant radiotherapy...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov